InstructorRoyed Training
TypeOnline Course
Student Enrolled1
Price$490 / 34300 INR.
Buy NowBook Now
Loading
Loading
Africa drug regulatory affairs

Introduction

Feature

Eligibility

Who should attend

Course Deliverable

Related Courses

About RA

Pharmaceutical Regulatory Affairs in Africa

The Advance Certification in Pharmaceutical Regulatory Affairs in Africa is a focused online training designed to equip professionals with the regulatory knowledge, strategic planning skills, and practical competencies needed to navigate the complex and evolving pharmaceutical regulatory landscapes across the African continent. This self-paced course delivers in-depth exposure to regulatory frameworks, market entry requirements, dossier preparation, and marketing authorization processes specific to key African countries.

This advance certification course in Pharmaceutical Regulatory Affairs covers drug registration, regulation and marketing authorization strategic planning for all African countries like Nigeria, Egypt, South Africa, Tanzania, Sudan etc.

In addition, this course is designed to challenge students and Professionals to apply what they have learned through the use of interactive exercises, reflection questions, and a final assessment at the end of the course.

The course can be completed at any place. So, it allows the user to stop and start at their leisure.

Course information at a glance

  • Course Code: RYD-067
  • Title of the course: Advance Certification in Pharmaceutical Regulatory Affairs in Africa
  • Duration : 1 Month
  • Types of course : Online distance learning course. Therefore, the course can be accessed online across anywhere 24×7.
  • Course Certificate : Certificate will be provided at the end of the successful completion of the course.

Why This Course Matters

Africa’s pharmaceutical sector is rapidly growing and represents a significant frontier for global pharmaceutical development, distribution, and export strategy. However, unlike centralized systems found in regions such as the EU or North America, each African country operates its own regulatory authority with distinct registration pathways, documentation requirements, and compliance norms. Understanding these local variations is vital for companies and professionals to secure timely marketing authorizations and enable compliant product access across diverse markets.

Regulatory harmonization initiatives such as the African Medicines Agency (AMA) and regional mutual recognition efforts are emerging, but they coexist with unique national protocols and language or documentation nuances. Upskilling in African regulatory affairs empowers regulatory professionals to interpret these evolving frameworks, reduce approval lead times, and strategically manage submissions across jurisdictions.

This African Drug Regulatory Affairs online course utilizes interactive learning tools to guide each participant through to understand of the regulatory process of the African pharmaceutical market. This online certification course will focus on understanding regulatory affairs strategic management skills which is required for effective functioning as regulatory personnel. Indeed, advance simulation in the course will challenge students to apply what they have learned from the course. In addition, there are advance learning tools like interactive exercises, reflection questions, expert live chat which makes the course very interesting. african drug regulatory affairs

Benefit of African Pharmaceutical Regulatory Affairs Course

  • Gain an overview of the regulatory environment in the Africa
  • Insight on the pharmaceutical markets in Africa
  • Understand the strategic pathway for marketing authorization in African countries
  • Harmonization and recent developments in the African region

Key features of the course

  • 24×7 Online Access. Therefore, access the course anytime from anywhere across globe.
  • Students can download the course materials from dashboard. Hence, it helps them to study offline even after completion of the course.
  • Access the e-lectures, case studies, self assessment modules and practical sessions through personalized web page. 
  • Moreover, final examination is online. Hence student can attend the final examination own convenient date and time. 

Graduation in any discipline. Even the final year student can join the course.

Who should attend

  • Those who want to know about the African Pharmaceutical Market, Regulation.
  • One want to enhance knowledge about the African countries latest regulatory updates.
  • Business Development, Regulatory Affairs, IPR, strategic management professionals who want to have the detailed understand strategic planning process for registration and regulation of the pharmaceuticals in African countries.
  1. Attend the course 24×7 by login to your dashboard. So, you can attend lectures, simulation, self assessment tests and final certification examination.
  2. You will also eligible to receive the course study modules. You can download by login to your course page.

Insight on African Market and Regulatory overview

A career in Regulatory Affairs is very challenging. But at the same time regulatory affairs career can be highly rewarding. It opens up lot of opportunities for professionals. But the regulatory job covers a variety of disciplines. Regulatory professional involved involved in regulatory submission, compliance, clinical trials, quality assurance, drug safety, pharmacovigilance.

The pharmaceutical market in the Africa has witnessed considerable progress over the years due to favorable demographic and economic factors. African pharmaceutical market is considered as semi regulated market. Africa’s pharmaceutical industry is valued around USD 29 billion, and it is one of the major export entry gateway for pharmaceutical companies.

Above all, there is a strong support from the government  for healthcare industry. Despite of the recent progress, the pharmaceutical sector in the Africa is still in an emerging phase. African market belongs to the class of semi regulated market. But drug regulation in African countries are evolving very fast. A vast majority of pharmaceuticals consumed in the region are of imported brand. However, the governments have been trying to increase local drug manufacturing. In turn, it will reduce reliance on imported products.

Africa’s pharmaceutical markets are growing very fast. Prescription drugs are forecast to grow at a compound annual growth rate of 6.5%, generics at 10%, over-the-counter medicines at 7.1%, and medical devices at 12.1%. Increasing urbanization, healthcare capacity and supportive business environment are the drivers of the Africa pharmaceutical market. For early movers in order to pursue competitive advantage requires focus on pockets of growth like much of the opportunity lies not at country level, but in cities. It is interesting to note that 37% of African consumers are concerted in 30 cities.

Challenges for pharmaceutical companies to market in Africa

One of the major challenge for pharmaceutical companies is  supply and distribution management. Africa, being vast continent, managing the supply chain will be challenging. Secondly, understanding the regulation is key most important for making the appropriate marketing authorization strategy. But it will be really challenging as region witness lot of pharmaceutical companies and there is no regulatory harmonization. So, understanding of regulatory strategic planning is crucial for success of pharmaceutical companies.

About regulatory affairs job>> Learn here

Section 1Drug Discovery Development to Commercialization - fundamental understanding
Lecture 1Introduction to Pharmaceutical R&D | Drug Discovery Development Process
Lecture 2Investigational New Drug Application (INDA)
Lecture 3New Drug Application (NDA) 
Lecture 4Basic concept and understanding of the Generic Drug
Lecture 5Abbreviated New Drug Application (ANDA) 
Lecture 6Handling of orange book
Lecture 7Complete Response Letter | Key understanding | Management and Action Plan
Lecture 8USFDA expedited programs
Lecture 9505(j) ANDA, 505(b)(2) NDA, 505(b)(1) NDA
Lecture 10Authorized Generics: Key Understanding
Lecture 11Exploratory IND Vs. Traditional IND
Lecture 12Orphan Drug Designation 
Lecture 13Advance Learning on 505B2 Pathway
Lecture 14Chemistry, Manufacturing & Controls 
Lecture 15Patent & Exclusivity - Strategic Understanding | Patent Restoration| Orphan Drug Exclusivity (ODE) | NCE & NCI Exclusivity | GAIN Exclusivity | Pediatric Exclusivity | 180 days exclusivity
Lecture 16Clinical Trials : Advance Understanding |
Lecture 17Clinical Trial Protocol Writing
Lecture 18Ethics in Clinical Research
Lecture 19Review on Drug Discovery and Development 
Lecture 20Fundamental of CMC | Detailed understanding of CMC section writing | Important Points regarding CMC | Drug Product and Drug Substance | Excipient, FP, Analysis and Stability Study Requirements
Section 2Africa continents
Lecture 21Overview - African Continent
Lecture 22Insight on African Pharma Market
Lecture 23Drug Registration - African medicines regulatory
Lecture 24Basic Export Requirement for African Countries
Lecture 25Export Documentations & Important Concepts
Lecture 26Africa Regulatory Landscape Harmonization | Strategic Pathways for Marketing Authorization
Lecture 27Africa Regulatory Strategic Pathway Mapping (All 55 Countries) [Royed Training]
Section 3Country specific regulation
Lecture 28Drug Registration and Regulation in Nigeria
Lecture 29Drug Registration and Regulation in Algeria
Lecture 30Drug Registration in Ethiopia
Lecture 31Drug Registration in Kenya
Lecture 32Drug Registration in Egypt
Lecture 33Drug Registration in Ghana
Lecture 34Drug Registration and Regulation in Botswana
Lecture 35Drug Registration and Regulation in South Africa
Lecture 36Drug Registration and Regulation in Zambia
Lecture 37Drug Registration and Regulation in Namibia
Lecture 38Drug Registration and Regulation in Tazania
Lecture 39Drug Registration and Regulation in Senegal
Lecture 40Drug Registration and Regulation in Zimbabwe
Lecture 41Drug Registration and Regulation in Uganda
Lecture 42Drug Registration and Regulation in Morocco
Lecture 43Drug Registration and Regulation in Sudan
Section 4Submission Dossier Preparation, filing and management
Lecture 44Introduction to Common Technical Document (CTD)
Lecture 45CMC Dossier & Compliance Management
Lecture 46Advance Practical Training on Dossier Preparation focusing on drug registration in export countries 
Lecture 47Key Consideration for Drug Master File Preparation and Submission 
Lecture 48Practical Understanding on Drug Master File Preparation and Submission
Lecture 49Site Master File - Detailed Understanding 
Lecture 50DMF Completeness Assessment
Lecture 51Importance of effective dossier management
Lecture 52Discussion on 85 common deficiencies in CTD submission dossier
Lecture 53Data Integrity issues in Pharmaceutical Industry : Detailed Understanding 
Lecture 54Plant Inspection Management
Lecture 55Electronic Batch Record for effective compliance management | Key Understanding | Functionalities | Importance in managing data integrity
Lecture 56Drug Master File - Global Perspective [Across Different Regions]
Section 5GMP requirements
Lecture 57Certification Pharmaceutical Companies / Plants 
Lecture 58Premises & Plant Layout Designing
Lecture 59Sanitation and Hygiene
Lecture 60Equipment
Lecture 61Production Modules
Lecture 62Documentation
Lecture 63Quality Control
Lecture 64Product Complaint
Lecture 65Storage Module
Section 6CPP and WHO Certification Scheme
Lecture 66Introduction to Certificate of Pharmaceutical Product | Types of CoPP | List of Countries / Regulatory Authorities who requires CoPP | CoPP as a part of generic market expansion planning 
Lecture 67WHO-GMP Certification Scheme 
Lecture 68Template of Certificate of Pharmaceutical product | Key observations and points to note while working on CoPP
Section 7Stability Study
Lecture 69Modules on Stability Study : Stability Study - Fundamental Understanding | Interchangebility | Reports | API & FPP Stability Study
Lecture 70Climatic Zone and Stability Study Conditions as per ICH Guidelines 
Lecture 71Stability Zone Finder
Lecture 72Stability Studies Case Discussions
Lecture 73Case Study: Managing Stability Study for Zone IV countries
Lecture 74Accelerated and intermediate testing conditions
Lecture 75Long Term Stability Testing Requirements
Lecture 76Testing Frequency
Lecture 77Bracketing
Lecture 78Matrixing
Lecture 79Critical Stability Scenarios | 8 Different Case Studies | Stability Study - Outcome based action plan creation
Lecture 80Critical Stability Issues - Database | Implication | Action Plan
Lecture 81Africa Stability Zone & Stability Requirements (All 55 Countries) | Practical execution rules for dossiers (Africa-wide) | Strategic Interpretation
Section 8PK/PD - BA/BE - Bioequivalence Study
Lecture 82PKPD in Drug Discovery | PK-PD trial | Understanding PKPD from regulatory perspective in drug approval process
Lecture 83Bioequivalence Study | Study design | Different types of BE Studies
Lecture 84Bioequivalence Study | Study design | Parallel Study | Crossover study design | Other alternative study designs | Blood Sampling Planning  | Analyte | Bioanalytical Methods Validation  | Statistical Model  | Ln Transformation  | Dose normalisation | Confidence interval acceptance criteria
Lecture 85Biopharmaceutical Classification System (BCS) | Types | Biowaivers | BCS tool for drug development and regulatory submission 
Lecture 86Bioequivalence Study - Discussion - Timeline of stability study and bioequivalence study 
Lecture 87Bioequivalence Study - Discussion - Dissolution Testing
Lecture 88Bioequivalence Study - Generic Approval and Additives Labeling Requirements 
Lecture 89Setting Dissolution Specification for Generic Products | Regulatory Expectations
Lecture 90Regulatory Requirements for Biosimilar | Stepwise evidence based development | Analytical Similarity | Clinical Study | PKPD study requirements | CMC expectation of Biosimilar
Lecture 91BA BE Study Design  | Comparing different types of the study design 
Lecture 922wco Study Design  | Design Table | Importance  
Lecture 933wco Study Design  | Design Table | Importance  
Lecture 94FRCO Study Design  | Design Table | Importance  
Lecture 95Parallel Vs. Crossover Study Design